Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Imipramine Inhibits Chikungunya Virus Replication in Human Skin Fibroblasts through Interference with Intracellular Cholesterol Trafficking.
Wichit S, Hamel R, Bernard E, Talignani L, Diop F, Ferraris P, Liegeois F, Ekchariyawat P, Luplertlop N, Surasombatpattana P, Thomas F, Merits A, Choumet V, Roques P, Yssel H, Briant L, Missé D. Wichit S, et al. Among authors: merits a. Sci Rep. 2017 Jun 9;7(1):3145. doi: 10.1038/s41598-017-03316-5. Sci Rep. 2017. PMID: 28600536 Free PMC article.
Prime-boost immunization strategies against Chikungunya virus.
Hallengärd D, Lum FM, Kümmerer BM, Lulla A, Lulla V, García-Arriaza J, Fazakerley JK, Roques P, Le Grand R, Merits A, Ng LF, Esteban M, Liljeström P. Hallengärd D, et al. Among authors: merits a. J Virol. 2014 Nov;88(22):13333-43. doi: 10.1128/JVI.01926-14. Epub 2014 Sep 10. J Virol. 2014. PMID: 25210177 Free PMC article.
Chikungunya virus (CHIKV) is a reemerging mosquito-borne alphavirus that causes debilitating arthralgia in humans. ...While humoral immunity seems to be central for protection against CHIKV infection, we do not yet fully understand the correlates of protection. Therefore, …
Chikungunya virus (CHIKV) is a reemerging mosquito-borne alphavirus that causes debilitating arthralgia in humans. ...While humoral i …
Therapeutics and vaccines against chikungunya virus.
Ahola T, Couderc T, Ng LF, Hallengärd D, Powers A, Lecuit M, Esteban M, Merits A, Roques P, Liljeström P. Ahola T, et al. Among authors: merits a. Vector Borne Zoonotic Dis. 2015 Apr;15(4):250-7. doi: 10.1089/vbz.2014.1681. Vector Borne Zoonotic Dis. 2015. PMID: 25897811 Review.
Antiviral activity of silymarin against chikungunya virus.
Lani R, Hassandarvish P, Chiam CW, Moghaddam E, Chu JJ, Rausalu K, Merits A, Higgs S, Vanlandingham D, Abu Bakar S, Zandi K. Lani R, et al. Among authors: merits a. Sci Rep. 2015 Jun 16;5:11421. doi: 10.1038/srep11421. Sci Rep. 2015. PMID: 26078201 Free PMC article.
Characterization of β-d-N4-Hydroxycytidine as a Novel Inhibitor of Chikungunya Virus.
Ehteshami M, Tao S, Zandi K, Hsiao HM, Jiang Y, Hammond E, Amblard F, Russell OO, Merits A, Schinazi RF. Ehteshami M, et al. Among authors: merits a. Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02395-16. doi: 10.1128/AAC.02395-16. Print 2017 Apr. Antimicrob Agents Chemother. 2017. PMID: 28137799 Free PMC article.
204 results